Company Filing History:
4 out of 10 
1 out of 832,891 Years Active: 2019-2021
Title: Michael Kiczun: Innovator in Pharmaceutical Compounds
Introduction
Michael Kiczun is a notable inventor based in Dundee, GB. He has made significant contributions to the field of medicine through his innovative pharmaceutical compounds. With a total of five patents to his name, Kiczun's work focuses on inhibitors that target specific enzymes involved in metabolic processes.
Latest Patents
Kiczun's latest patents include a pharmaceutical compound that provides a tryptophan-2,3-dioxygenase (TDO) and/or indoleamine-2,3-dioxygenase (IDO) inhibitor for medical use. This compound is characterized by a complex formula involving various elements such as carbon, nitrogen, oxygen, and sulfur. Another significant patent involves indole derivatives that also serve as TDO and IDO inhibitors, showcasing his expertise in developing compounds that can potentially lead to advancements in medical treatments.
Career Highlights
Throughout his career, Kiczun has worked with Iomet Pharma Ltd., where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding of enzyme inhibitors and their applications in medicine.
Collaborations
Kiczun has collaborated with notable professionals in the field, including Phillip Martin Cowley and Alan Wise. These collaborations have further enriched his research and development efforts.
Conclusion
Michael Kiczun stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative compounds that have the potential to impact medical science significantly. His contributions continue to pave the way for future advancements in the field.